Amygdala Insula Retraining in the Management of Perimenopause Symptoms
Recruiting
N/A
Interventional Study
Perimenopause
Menopausal Complaints
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 38 – 60
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 160 (estimated)
- Sponsor
- Chronic Conditions Research Fund · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to evaluate a neuroplasticity-based mind-body intervention, Amygdala and Insula Retraining (AIR), compared to a wait-list control in individuals experiencing perimenopausal symptoms.
Our research questions include:
Does AIR reduce overall perimenopausal symptom burden compared to a wait-list control?
Does AIR improve sleep disturbance, vasomotor symptom interference, f…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Experiencing perimenopausal symptoms
* Meets STRAW+10 criteria based on self-assessment (-2 to +1c)
* Able to read and understand English
* Access to internet
Exclusion Criteria:
* Pregnancy
* Presence of a severe psychiatric condition requiring immediate clinical interventi…
Contacts
No contact information available.